| Autor: |
Fonk, Lorna Grech, Ferreira, Teresa A, Webb, Andrew G, Luyten, Gregorius PM, Beenakker, Jan-Willem M |
| Předmět: |
|
| Zdroj: |
Clinical Ophthalmology; Apr2020, Vol. 14, p1135-1143, 9p |
| Abstrakt: |
aim in this paper was to determine the economic value of MRI for UM treatment. Methods: We retrospectively analysed 60 patients' MRI scans acquired as part of a study or for clinical care. For each patient, we assessed whether the extra cost of an MRI generated economic benefit or change in optimal treatment. Results: MRI indicated a smaller tumour prominence than US in 10% of patients with intermediate tumour size, resulting in a change from PBT to brachytherapy. The costs of MRI, € 200–€ 1000, are significantly lower than the higher costs of PBT compared to brachytherapy, € 24,000 difference. In addition, the annual total economic burden of severe vision impairment associated with eye removal is € 10,000. Furthermore, for patients where ultrasound was impossible due to previous surgery, MRI enabled eye-preserving treatment. Conclusion: An additional MRI for specific patients with UM improves economic value as it enables less expensive treatment in a sufficient percentage of patients to compensate for the MRI costs. Value is increased in terms of quality of care as it enables for some a treatment option which spares more vision. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|
